Ansell Limited (ASX:ANN)
34.88
+0.32 (0.93%)
Aug 11, 2026, 4:10 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 4.8 billion as of August 10, 2026. Its market cap has increased by 6.08% in one year.
Market Cap
4.80B
Enterprise Value
5.72B
Revenue
3.01B
Ranking
n/a
PE Ratio
24.81
Stock Price
34.88
ChartMarket Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.80B, a decrease of -3.93%. That is a compound annual growth rate of -0.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 4.80B | -3.79% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 64.40B |
| Sigma Healthcare | 34.05B |
| Pro Medicus | 18.45B |
| Sonic Healthcare | 11.07B |
| Ramsay Health Care | 10.31B |
| Cochlear | 8.31B |
| Telix Pharmaceuticals | 5.65B |
| Mesoblast | 3.07B |